A resurgence of LBO loan supply from multiyear lows has altered the funding landscape for sponsor-backed deals. There’s a clear need to offer up larger equity checks into the financing mix, and to structure deals with better leverage and ratings profiles as higher base rates squeeze interest coverage capacity.
The key highlights of LCD’s analysis of LBO deals clearing the broadly syndicated loan market are as follows:
- Dividend deals outnumber LBOs
- Interest coverage has fallen to just 2.3x, a record low
- Equity contributions are hovering near 50%
- Lower leverage and higher-rated deals have found favor
Aided by expectations of falling borrowing costs ahead of the Federal Reserve’s commencement of interest rate cuts in September, the count of LBOs financed in the broadly syndicated market doubled to 18 in the third quarter, the highest quarterly count since the cycle’s first-rate hike of Q1 2022.
After a slight dip in the second quarter, US LBO transaction volume increased to $44.4 billion in Q3, based on debt and equity raised, bringing the total through three quarters in 2024 to $125.7 billion, roughly on a par with the same period of 2023.
However, when looking at the debt portion funded in the loan market, sponsors last quarter raised the most via broadly syndicated institutional loan funding since Q1 2022, at $22.1 billion. This brings institutional supply through three quarters to $53.5 billion this year, a 61% increase from $28.5 billion issued in the same period of 2023.
A meaningful revival of LBO activity was predicated on the expected path of interest rates and falling funding costs. As expectations of a 50 basis point cut grew, borrowers were further encouraged by falling yields and contracting spread costs to the underlying base rate. On average, private equity sponsors funded LBO deals at a yield of 9.41% in the third quarter, comparing favorably to the lofty highs of 10.91% in 2023. On a spread basis, investors received 383 bps above the base rate, down from 446 bps in 2023.
Indeed, yield buyers on the investor side — further encouraged by a long-standing shortage of new paper in which to put money to work — are still netting nearly 4.5% more on average compared to pre-rate hike times such as 2021, when the average yield was just 5.01%.
While it is still early in the recovery, and volumes remain below historical trend lines, there are several clear impacts of higher funding costs that could endure for as long as rates remain elevated.
For one, in an effort to lower expensive leverage, especially given relatively high purchase price multiples, sponsor companies continue to offer historically high equity infusions into the funding mix. The equity contribution averaged 49% in the first three quarters, and in Q3, it was 52%.
By comparison, a record year for equity contribution in 2023, at 51%, marked a significant jump from 46% in 2022.
Secondly, higher equity contributions, higher debt funding costs, and still relatively conservative risk tolerance on the investor side are keeping a lid on leverage multiples of new issues, at 5.07x on average this year. As of the third quarter, total leverage on deals financed in the leveraged loan market stood at 4.95x, based on pro forma financials at closing.
By comparison, in 2022, where issuance was front-loaded into the first half of the year ahead of accelerating rate hikes, leverage multiples were as high as 5.93x.
In addition to lower leverage profiles, the better-rated credits are finding placement in the broadly syndicated markets in higher numbers than in the years leading up to the rate hike cycle.
So far this year, 27% of issuance came from B-minus rated companies, and 65% from B flat or B+ rated issuers. Though higher than in 2023, when just 5% were B-minus rated, in 2022, and 2021, the B-minus shares were 68% and 56%, respectively.
Of course, this is in part a function of higher base rates, where high leverage is less tenable, and where interest coverage capacity is inevitably squeezed.
Regarding interest coverage, as the benchmark rate remained in a 5.25%-5.50% range until Sept. 18, interest coverage this year fell to just 2.3x, a record low.
By comparison, interest coverage in 2021, pre rate hike cycle, was 3.47x.
In the changing landscape of broadly syndicated LBO financing, private credit has stepped in as an alternative source of financing for debt raises. With that, a shift is also evident in LBO transaction sizes among those funding in the broadly syndicated markets. This year, 90% of transactions have been for $1 billion or more, based on debt and equity raised. In the pre-rate hike year of 2021, 74% of transactions were for $1 billion or more.
This trend reflects how smaller and riskier deals have migrated to private credit in greater numbers than in the quarters prior to the rate hikes. In Q3, LCD tracked 63 leveraged buyouts funding with private credit, representing 78% of deals tracked. This brings the share of LBOs financed in private credit this year to 84%. In the same period of 2021, the share of private credit was 60%.
Record debt-fueled dividends
Alongside leveraging for new buyouts, re-leveraging by PE firms in the broadly syndicated markets to fund dividend distributions is running at the highest level on record.
Amid wide-open financial conditions, private equity-backed borrowers tapped the loan market for $60.7 billion for dividend recaps in the first three quarters of the year, surpassing the same period of the record-setting year in 2021.
Amid sparse exit activity, the redeployment of capital has slowed, as has the ability of private equity firms to realize exits from their holdings, further encouraging the use of debt-funded dividends.
According to PitchBook, the median age for PE portfolio companies in the US was 4.1 years in 2023, a 10-year high, while the median hold period for exited companies last year was an all-time high of 7.1 years.
Pushing the envelope in size was the deal for Belron, which priced the largest dividend recap of all time. The auto glass repair priced an €8.1 billion-equivalent cross-border bond and loan financing, $4.7 billion (€4.2 billion) of which funding in the US BSL market.
Despite previous dividend recapitalizations, Belron, per S&P Global Ratings, has a track record of maintaining leverage at 3.0x-3.5x. However, citing projected leverage of 5.1x in 2025 (after peaking at about 5.8x in 2024) on account of this transaction, S&P Global Ratings hit the issuer with a three-notch downgrade to BB-, from BBB-. Moody’s, meanwhile, lowered the company to Ba3, from Ba1, estimating an increase in pro forma Moody’s-adjusted debt/EBITDA for the last 12 months ending June 30, 2024, to 6.1x, from the current level of 3.5x, and pro forma Moody’s-adjusted EBITA/interest expense to decrease to around 2x, from 4.2x.
While Belron’s leverage build is significant, companies this year, on average, are adding less leverage with dividend deals than has historically been the case amid the trend to better rated credits. LCD data shows that over the past 10 years to the end of 2023, sponsors added another 1.4 turns of leverage to companies for the purposes of dividend distributions, peaking at 1.7x in 2011, 2014, and 2022.
In the first three quarters this year, leverage as a result of dividend recapitalizations — and the trend to higher-rated issuers — increased to 4.8x.
Though still below historical norms, secondary buyouts as an exit route are increasing. The share of transaction counts of the sale of one portfolio company to another rose to 36% in the first three quarters.
Going forward, markets are expecting M&A and LBO activity to accelerate as risk appetite improves. LCD’s survey suggests investors will increase their tolerance for leverage, though equity contributions could remain above historical levels.
Featured image: WOWstockfootage/Getty Images
Learn about our editorial standards.


